Oak Grove Capital’s CVS Health CVS Stock Holding History

Oak Grove Capital’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-75	Closed	-$5K	–	163
2018 Q1	$5K	Buy	+75	New	+$5.38K	0.01%	134

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Oak Grove Capital's CVS Position: Q2 2018 in Review

Oak Grove Capital sold out of CVS Health (CVS) in Q2 2018, closing a stake of 75 shares — an estimated $5K sold.

Oak Grove Capital first reported a position in CVS in Q1 2018 and held it in 1 quarter. The position peaked at $5K in Q1 2018. 1,573 funds tracked by Wall St. Rank hold CVS as of Q2 2018.

Oak Grove Capital reported no remaining CVS Health position as of Q2 2018 after selling out during the quarter.
Oak Grove Capital sold 75 CVS Health shares in Q2 2018, an estimated $5K.
Oak Grove Capital first reported a position in CVS Health in Q1 2018 and held it in 1 quarter.
Oak Grove Capital's CVS Health position peaked at $5K in Q1 2018.
1,573 funds tracked by Wall St. Rank held CVS Health as of Q2 2018.

Based on Oak Grove Capital's 13F filing for Q2 2018, filed 9 Nov 2018.